Skip to content

Articles

Long-term outcome of Crohn’s disease patients with upper gastrointestinal stricture: a GETAID study

Articles,2020
T. Lambin, A. Amiot, J.M. Gornet, P. Seksik, D. Laharie, E. Louis, C. Giletta, J. Filippi, M. Fumery, G. Cadiot, G. Pineton de Chambrun, S. Nahon, M. Serrero, B. Coffin, L. Plastaras, S. Viennot,…
Lire la suite

IMPACT OF AN EDUCATION PROGRAM ON IBD PATIENT’S SKILLS: RESULTS OF A RANDOMIZED CONTROLLED MULTICENTER STUDY (ECIPE)

Articles,2020
J. Moreau, L. Marthey, C. Trang, M. Nachury, R. Altwegg, J.-C. Grimaud, S. Orempuller, J. Filippi, A. Aubourg, C. Baudry,P. Seksik, X. Roblin, S. Nahon, G. Savoye, B. Mesnard,C. Stefanescu, M. Simon, B. Coffin,…
Lire la suite

Surgery for Crohn’s disease during pregnancy: A nationwide survey

Articles,2020
Germain A, Chateau T, Beyer-Berjot L, Zerbib P, Lakkis Z, Amiot A, Buisson A, Laharie D, Lefevre JH, Nancey S, Stefanescu C, Bresler L, Peyrin-Biroulet L (United European Gastroenterol J. 2020 Jul;8(6):736-740 – PMID: 32326876)…
Lire la suite

Efficacy and Safety of Tumor Necrosis Factor Antagonists in Treatment of Internal Fistulizing Crohn’s Disease

Articles,2020
Bouguen G, Huguet A, Amiot A, Viennot S, Cholet F, Nachury M, Flamant M, Reimund JM, Desfourneaux V, Boureille A, Siproudhis L (Clin Gastroenterol Hepatol. 2020 Mar;18(3):628-636 – PMID: 31128337) https://pubmed.ncbi.nlm.nih.gov/31128337/
Lire la suite

Dose De-Escalation to Adalimumab 40 Mg Every Three Weeks in Patients With Inflammatory Bowel disease-A Multicenter, Retrospective, Observational Study

Articles,2019
Lieven Pouillon , Anne Lamoureux , Guillaume Pineton de Chambrun , Lucine Vuitton , Benjamin Pariente , Camille Zallot , Gaspard Dufour , Mathurin Fumery , Cédric Baumann , Aurélien Amiot , Stéphane Nancey…
Lire la suite

Efficacy and Safety of Induction Therapy With Calcineurin Inhibitors in Combination With Vedolizumab in Patients With Refractory Ulcerative Colitis.

Articles,2019
Pellet G, Stefanescu C, Carbonnel F, Peyrin-Biroulet L, Roblin X, Allimant C, Nachury M, Nancey S, Filippi J, Altwegg R, Brixi H, Fotsing G, de Rosamel L, Shili S, Laharie D (Clin Gastroenterol Hepatol.…
Lire la suite

Effectiveness and safety of ustekinumab induction therapy for 103 patients with ulcerative colitis: a GETAID multicentre real-world cohort study

Articles,2020
Amiot A, Filippi J, Abitbol V, Cadiot G, Laharie D, Serrero M, Altwegg R, Bouhnik Y, Peyrin-Biroulet L, Gilletta C, Roblin X, Pineton de Chambrun G, Vuitton L, Bourrier A, Nancey S, Gornet JM,…
Lire la suite

Vedolizumab for perianal Crohn’s disease: a multicentre cohort study in 151 patients

Articles,2020
Chapuis-Biron C, Bourrier A, Nachury M, Nancey S, Bouhnik Y, Serrero M, Armengol-Debeir L, Buisson A, Tran-Minh ML, Zallot C, Fumery M, Bouguen G, Abitbol V, Viennot S, Chanteloup E, Rajca S, Dib N,…
Lire la suite

Maintenance of remission among patients with inflammatory bowel disease after vedolizumab discontinuation: a multicentre cohort study.

Articles,2020
Martin A, Nachury M, Peyrin-Biroulet L, Bouhnik Y, Nancey S, Bourrier A, Serrero M, Fumery M, Buisson A, Laharie D, Gilletta C, Filippi J, Allez M, Bouguen G, Roblin X, Altwegg R, Dib N,…
Lire la suite

A clinical decision support tool may help to optimise vedolizumab therapy in Crohn’s disease

Articles,2020
Dulai PS, Amiot A, Peyrin-Biroulet L, Jairath V, Serrero M, Filippi J, Singh S, Pariente B, Loftus EV Jr, Roblin X, Kane S, Buisson A, Siegel CA, Bouhnik Y, Sandborn WJ, Lasch K, Rosario…
Lire la suite

Efficacy of Tumor Necrosis Factor Antagonist Treatment in Patients With Refractory Ulcerative Proctitis

Articles,2020
Pineton de Chambrun G, Amiot A, Bouguen G, Viennot S, Altwegg R, Louis E, Collins M, Fumery M, Poullenot F, Armengol L, Buisson A, Abitbol V, Laharie D, Seksik P, Nancey S, Blanc P,…
Lire la suite

Monitoring a Combination of Calprotectin and Infliximab Identifies Patients With Mucosal Healing of Crohn’s Disease

Articles,2020
Dreesen E, Baert F, Laharie D, Bossuyt P, Bouhnik Y, Buisson A, Lambrecht G, Louis E, Oldenburg B, Pariente B, Pierik M, van der Woude CJ, D’Haens G, Vermeire S, Gils A (Clin Gastroenterol…
Lire la suite

Real-world evidence of tofacitinib effectiveness and safety in patients with refractory ulcerative colitis

Articles,2020
Lair-Mehiri L, Stefanescu C, Vaysse T, Laharie D, Roblin X, Rosa I, Treton X, Abitbol V, Amiot A, Bouguen G, Dib N, Fumery M, Pariente B, Carbonnel F, Peyrin-Biroulet L, Simon M, Viennot S,…
Lire la suite

Efficacy and safety of golimumab in Crohn’s disease: a French national retrospective study

Articles,2017
Martineau C, Flourié B, Wils P, Vaysse T, Altwegg R, Buisson A, Amiot A, de Chambrun GP, Abitbol V, Fumery M, Hébuterne X, Viennot S, Laharie D, Beaugerie L, Nancey S, Sokol H (Aliment…
Lire la suite

Infliximab Exposure Associates With Radiologic Evidence of Healing in Patients With Crohn’s Disease

Articles,2017
Bossuyt P, Dreesen E, Rimola J, Devuysere S, De Bruecker Y, Vanslembrouck R, Laurent V, Zappa M, Savoye-Collet C, Pariente B, Filippi J, Baert F, D’haens G, Laharie D, Peyrin-Biroulet L, Vermeire S (Aliment…
Lire la suite

Methotrexate Is Not Superior to Placebo for Inducing Steroid-Free Remission, but Induces Steroid-Free Clinical Remission in a Larger Proportion of Patients With Ulcerative Colitis

Articles,2016
Carbonnel F, Colombel JF, Filippi J, Katsanos KH, Peyrin-Biroulet L, Allez M, Nachury M, Novacek G, Danese S, Abitbol V, Bossa F, Moreau J, Bommelaer G, Bourreille A, Fumery M, Roblin X, Reinisch W,…
Lire la suite

Long-term outcome of patients with steroid-refractory acute severe UC treated with ciclosporin or infliximab

Articles,2016
Laharie D, Bourreille A, Branche J, Allez M, Bouhnik Y, Filippi J, Zerbib F, Savoye G, Vuitton L, Moreau J, Amiot A, Cosnes J, Ricart E, Dewit O, Lopez-Sanroman A, Fumery M, Carbonnel F,…
Lire la suite

Effectiveness and Safety of Vedolizumab Induction Therapy for Patients With Inflammatory Bowel Disease

Articles,2016
Amiot A, Grimaud JC, Peyrin-Biroulet L, Filippi J, Pariente B, Roblin X, Buisson A, Stefanescu C, Trang-Poisson C, Altwegg R, Marteau P, Vaysse T, Bourrier A, Nancey S, Laharie D, Allez M, Savoye G,…
Lire la suite

One-year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multicentre cohort study.

Articles,2017
Amiot A, Serrero M, Peyrin-Biroulet L, Filippi J, Pariente B, Roblin X, Buisson A, Stefanescu C, Trang-Poisson C, Altwegg R, Marteau P, Vaysse T, Bourrier A, Nancey S, Laharie D, Allez M, Savoye G,…
Lire la suite

Long-term Follow-up After Ileorectal Anastomosis for Ulcerative Colitis: A GETAID/GETAID Chirurgie Multicenter Retrospective Cohort of 343 Patients.

Articles,2017
Uzzan M, Cosnes J, Amiot A, Gornet JM, Seksik P, Cotte E, Tiret E, Panis Y, Treton X. (Ann Surg . 2017 Dec;266(6):1029-1034 – PMID: 27655238) https://pubmed.ncbi.nlm.nih.gov/27655238/
Lire la suite

Endoscopic Detection of Small Bowel Dysplasia and Adenocarcinoma in Crohn’s Disease: A Prospective Cohort-Study in High-Risk Patients.

Articles,2017
Simon M, Cosnes J, Gornet JM, Seksik P, Stefanescu C, Blain A, Pariente B, Nancey S, Vuitton L, Nachury M, D’Haens G, Filippi J, Chevret S, Laharie D (J Crohns Colitis. 2017 Jan;11(1):47-52 –…
Lire la suite

Anti-TNF therapy for genital fistulas in female patients with Crohn’s disease: a nationwide study from the Groupe d’Etude Thérapeutique des Affections Inflammatoires du tube Digestif (GETAID).

Articles,2018
Le Baut G, Peyrin-Biroulet L, Bouguen G, Gornet JM, Stefanescu C, Amiot A, Laharie D, Altwegg R, Fumery M, Trang C, Vuitton L, Simon M, Gilletta de Saint Joseph C, Nahon S, Caillo L,…
Lire la suite

Risk of serious infection in healthcare workers with inflammatory bowel disease: a case-control study of the Groupe d’Etude Thérapeutique des Affections Inflammatoires du tube Digestif (GETAID).

Articles,2018
Charlotte Gagnière , Anne Bourrier , Philippe Seksik , Jean-Marc Gornet , Olivier DeWit , Stephane Nancey , Romain Altwegg , Vered Abitbol , David Laharie , Catherine Reenaers , Anthony Buisson , Benjamin…
Lire la suite

Increasing Infliximab Dose Based on Symptoms, Biomarkers, and Serum Drug Concentrations Does Not Increase Clinical, Endoscopic, and Corticosteroid-Free Remission in Patients With Active Luminal Crohn’s Disease

Articles,2018
Geert D’Haens , Severine Vermeire , Guy Lambrecht , Filip Baert , Peter Bossuyt , Benjamin Pariente , Anthony Buisson , Yoram Bouhnik, Jérôme Filippi , Janneke Vander Woude , Philippe Van Hootegem ,…
Lire la suite

Long-term efficacy and safety of ustekinumab in 122 refractory Crohn’s disease patients: a multicentre experience.

Articles,2018
Wils P, Bouhnik Y, Michetti P, Flourie B, Brixi H, Bourrier A, Allez M, Duclos B, Serrero M, Buisson A, Amiot A, Fumery M, Roblin X, Peyrin-Biroulet L, Filippi J, Bouguen G, Abitbol V,…
Lire la suite

Impact of vedolizumab therapy on extra-intestinal manifestations in patients with inflammatory bowel disease: a multicentre cohort study nested in the OBSERV-IBD cohort.

Articles,2018
Tadbiri S, Peyrin-Biroulet L, Serrero M, Filippi J, Pariente B, Roblin X, Buisson A, Stefanescu C, Trang-Poisson C, Altwegg R, Marteau P, Vaysse T, Bourrier A, Nancey S, Laharie D, Allez M, Savoye G,…
Lire la suite

Outcomes 7 Years After Infliximab Withdrawal for Patients With Crohn’s Disease in Sustained Remission.

Articles,2018
Reenaers C, Mary JY, Nachury M, Bouhnik Y, Laharie D, Allez M, Fumery M, Amiot A, Savoye G, Altwegg R, Devos M, Malamut G, Bourreille A, Flourie B, Marteau P, Vuitton L, Coffin B,…
Lire la suite

Features of Autoimmune Pancreatitis Associated With Inflammatory Bowel Diseases

Articles,2018
Lorenzo D, Maire F, Stefanescu C, Gornet JM, Seksik P, Serrero M, Bournet B, Marteau P, Amiot A, Laharie D, Trang C, Coffin B, Bellaiche G, Cadiot G, Reenaers C, Racine A, Viennot S,…
Lire la suite

Efficacy of adalimumab in patients with Crohn’s disease and symptomatic small bowel stricture: a multicentre observational cohort (CREOLE) study.

Articles,2018
Yoram Bouhnik , Franck Carbonnel , David Laharie , Carmen Stefanescu , Xavier Hébuterne , Vered Abitbol , Maria Nachury , Hedia Brixi , Arnaud Bourreille , Laurence Picon , Anne Bourrier , Matthieu…
Lire la suite

Are random biopsies still useful for the detection of neoplasia in patients with IBD undergoing surveillance colonoscopy with chromoendoscopy?

Articles,2018
Moussata D, Allez M, Cazals-Hatem D, Treton X, Laharie D, Reimund JM, Bertheau P, Bourreille A, Lavergne-Slove A, Brixi H, Branche J, Gornet JM, Stefanescu C, Moreau J, Marteau P, Pelletier AL, Carbonnel F,…
Lire la suite

Three-year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multi-centre cohort study

Articles,2019
Amiot A, Serrero M, Peyrin-Biroulet L, Filippi J, Pariente B, Roblin X, Buisson A, Stefanescu C, Trang-Poisson C, Altwegg R, Marteau P, Vaysse T, Bourrier A, Nancey S, Laharie D, Allez M, Savoye G,…
Lire la suite

Vedolizumab Therapy is Ineffective for Primary Sclerosing Cholangitis in Patients With Inflammatory Bowel Disease: A GETAID Multicentre Cohort Study.

Articles,2019
Caron B, Peyrin-Biroulet L, Pariente B, Bouhnik Y, Seksik P, Bouguen G, Caillo L, Laharie D, Carbonnel F, Altwegg R, Reenaers C, Serrero M, Trang-Poisson C, Nancey S, Filippi J, Abitbol V, Savoye G,…
Lire la suite

Adalimumab for Patients With Crohn’s Disease Complicated by Intra-Abdominal Abscess: A Multicentre, Prospective, Observational Cohort Study

Articles,2019
G Pineton de Chambrun , B Pariente , P Seksik , R Altwegg , L Vuitton , C Stefasnescu , S Nancey , A Aubourg , M Serrero , L Peyrin-Biroulet , J Filippi…
Lire la suite

Anti-neutrophil cytoplasmic auto-antibodies (ANCA) in ulcerative colitis (UC): no relationship with disease activity.

Articles,2000
Reumaux D, Colombel JF, Masy E, Duclos B, Heresbach D, Belaïche J, Cortot A, Duthilleul P (Inflamm Bowel Dis. 2000 Nov;6(4):270-4 – PMID: 11149558) https://pubmed.ncbi.nlm.nih.gov/11149558/
Lire la suite

Serum calprotectin as a biomarker for Crohn’s disease.

Articles,2013
Meuwis MA, Vernier-Massouille G, Grimaud JC, Bouhnik Y, Laharie D, Piver E, Seidel L, Colombel JF, Louis E (J Crohns Colitis. 2013 Dec;7(12):e678-83. – PMID: 23845231) https://pubmed.ncbi.nlm.nih.gov/23845231/
Lire la suite

Milder multiple sclerosis course in patients with concomitant inflammatory bowel disease.

Articles,2014
Zéphir H, Gower-Rousseau C, Salleron J, Simon O, Debouverie M, Le Page E, Bouhnik Y, Lebrun-Frenay C, Papeix C, Vigneron B, Allez M, Prin L, Cosnes J, Vermersch P, Colombel JF (Mult Scler. 2014…
Lire la suite

Structural robustness of the gut mucosal microbiota is associated with Crohn’s disease remission after surgery

Articles,2016
Mondot S, Lepage P, Seksik P, Allez M, Tréton X, Bouhnik Y, Colombel JF, Leclerc M, Pochart P, Doré J, Marteau P (Gut. 2016 Jun;65(6):954-62. – PMID: 26628508) https://pubmed.ncbi.nlm.nih.gov/26628508/
Lire la suite

Reproducibility of colonoscopic findings in Crohn’s disease: a prospective multicenter study of interobserver variation. Groupe d’Etudes Therapeutiques des Affections Inflammatoires du Tube Digestif (GETAID).

Articles,1987
(Dig Dis Sci. 1987 Dec;32(12):1370-9. – PMID: 3319454) https://pubmed.ncbi.nlm.nih.gov/3319454/
Lire la suite

Severe skin lesions cause patients with inflammatory bowel disease to discontinue anti-tumor necrosis factor therapy.

Articles,2010
Rahier JF, Buche S, Peyrin-Biroulet L, Bouhnik Y, Duclos B, Louis E, Papay P, Allez M, Cosnes J, Cortot A, Laharie D, Reimund JM, Lémann M, Delaporte E, Colombel JF (Clin Gastroenterol Hepatol. 2010…
Lire la suite

Efficacy of a third anti-TNF monoclonal antibody in Crohn’s disease after failure of two other anti-TNF

Articles,2010
Allez M, Mozziconacci N, Vermeire S, Laharie D, Louis E, Bigard MA, Hebuterne X, Bouhnik Y, Kohn A, van Assche G, Lemann M, Rutgeerts P, Colombel JF. (Aliment Pharmacol Ther ; 2010 Jan;31(1):92-101 –…
Lire la suite

Successive treatment with cyclosporine and infliximab in steroid-refractory ulcerative colitis.

Articles,2011
Leblanc S, Allez M, Seksik P, Flourie B, Peeters H, Dupas JL, Bouguen G, Peyrin-Biroulet L, Duclos B, Bourreille A, Dewit O, Bouhnik Y, Michetti P, Chaussade S, Saussure P, Mary JY, Colombel JF,…
Lire la suite

Maintenance of Remission Among Patients with Crohn’s Disease on Anti-Metabolite Therapy after Infliximab Therapy is Stopped.

Articles,2012
Louis E, Mary JY, Vernier-Massouille G, Grimaud JC, Bouhnik Y, Laharie D, Dupas JL, Pillant H, Picon L, Veyrac M, Flamant M, Savoye G, Jian R, Devos M, Porcher R, Paintaud G, Piver E,…
Lire la suite

Long-term outcome of enterocutaneous fistula in patients with Crohn’s disease treated with anti-TNF therapy: a cohort study from the GETAID.

Articles,2014
Amiot A, Setakhr V, Seksik P, Allez M, Treton X, De Vos M, Laharie D, Colombel JF, Abitbol V, Reimund JM, Moreau J, Veyrac M, Flourie B, Cosnes J, Lemann M, Bouhnik Y. (Am…
Lire la suite

Factors associated with pregnancy outcome in anti-TNF treated women with inflammatory bowel disease.

Articles,2014
Seirafi M, de Vroey B, Amiot A, Seksik P, Roblin X, Allez M, Peyrin-Biroulet L, Marteau P, Cadiot G, Laharie D, Boureille A, De Vos M, Savoye G, Rahier JF, Carbonnel F, Bonaz B,…
Lire la suite

Alopecia areata occurring during anti-TNF therapy: a national multicenter prospective study.

Articles,2014
Tauber M, Buche S, Reygagne P, Berthelot JM, Aubin F, Ghislain PD, Cohen JD, Coquerelle P, Goujon E, Jullien D, Brixi H, Jeudy G, Guennoc X, Martin A, Brénaut E, Hoppé E, Bertolotti A,…
Lire la suite

Alterations in the intestinal microbiome (dysbiosis) as a predictor of relapse after infliximab withdrawal in Crohn’s disease

Articles,2014
Rajca S, Grondin V, Louis E, Vernier-Massouille G, Grimaud JC, Bouhnik Y, Laharie D, Dupas JL, Pillant H, Picon L, Veyrac M, Flamant M, Savoye G, Jian R, Devos M, Paintaud G, Piver E,…
Lire la suite

Standardizing terms definitions and concepts for describing and interpreting unwanted immunogenicity of biopharmaceuticals: recommendations of the Innovative Medicines Initiative ABIRISK consortium.

Articles,2015
B Rup , M Pallardy , D Sikkema , T Albert , M Allez , P Broet , C Carini , P Creeke , J Davidson , N De Vries , D Finco ,…
Lire la suite

Costs of Crohn’s Disease According to Severity States in France: A Prospective Observational Study and Statistical Modeling over 10 Years.

Articles,2016
Boschetti G, Nancey S, Daniel F, Pariente B, Lerebours E, Duclos B, Bourreille A, Cadiot G, Fumery M, Moreau J, Marteau P, Bouhnik Y, Louis E, Flourie B (Inflamm Bowel Dis. 2016 Dec;22(12) –…
Lire la suite

Negative Screening Does Not Rule Out the Risk of Tuberculosis in Patients with Inflammatory Bowel Disease Undergoing Anti-TNF Treatment: A Descriptive Study on the GETAID Cohort.

Articles,2016
Abitbol Y, Laharie D, Cosnes J, Allez M, Nancey S, Amiot A, Aubourg A, Fumery M, Altwegg R, Michetti P, Chanteloup E, Seksik P, Baudry C, Flamant M, Bouguen G, Stefanescu C, Bourrier A,…
Lire la suite

Interobserver Variation Study of the Rutgeerts Score to Assess Endoscopic Recurrence after Surgery for Crohn’s Disease.

Articles,2016
Marteau P, Laharie D, Colombel JF, Martin L, Coevoet H, Allez M, Cadiot G, Bourreille A, Carbonnel F, Bouhnik Y, Coffin B, Duclos B, Dupas JL, Moreau J, Louis E, Mary JY (J Crohns…
Lire la suite

Risk of Incident Cancer in Inflammatory Bowel Disease Patients Starting Anti-TNF Therapy While Having Recent Malignancy.

Articles,2016
Poullenot F, Seksik P, Beaugerie L, Amiot A, Nachury M, Abitbol V, Stefanescu C, Reenaers C, Fumery M, Pelletier AL, Nancey S, Peyrin-Biroulet L, Bourreille A, Hébuterne X, Brixi H, Savoye G, Lourenço N,…
Lire la suite

Fistula Plug in Fistulising Ano-Perineal Crohn’s Disease: a Randomised Controlled Trial.

Articles,2016
Senéjoux A, Siproudhis L, Abramowitz L, Munoz-Bongrand N, Desseaux K, Bouguen G, Bourreille A, Dewit O, Stefanescu C, Vernier G, Louis E, Grimaud JC, Godart B, Savoye G, Hebuterne X, Bauer P, Nachury M,…
Lire la suite

Subcutaneous Ustekinumab Provides Clinical Benefit for Two-Thirds of Patients With Crohn’s Disease Refractory to Anti-Tumor Necrosis Factor Agents.

Articles,2016
Wils P, Bouhnik Y, Michetti P, Flourie B, Brixi H, Bourrier A, Allez M, Duclos B, Grimaud JC, Buisson A, Amiot A, Fumery M, Roblin X, Peyrin-Biroulet L, Filippi J, Bouguen G, Abitbol V,…
Lire la suite

Mapping of a susceptibility locus for Crohn’s disease on chromosome 16. Nature.

Articles,1996
Hugot JP, Laurent-Puig P, Gower-Rousseau C, Olson JM, Lee JC, Beaugerie L, Naom I, Dupas JL, Van Gossum A, Orholm M, Bonaiti-Pellie C, Weissenbach J, Mathew CG, Lennard-Jones JE, Cortot A, Colombel JF, Thomas…
Lire la suite

Clinical characteristics of Crohn’s disease in 72 families. Gastroenterology.

Articles,1996
Colombel JF, Grandbastien B, Gower-Rousseau C, Plegat S, Evrard JP, Dupas JL, Gendre JP, Modigliani R, Belaiche J, Hostein J, Hugot JP, van Kruiningen H, Cortot A. (1996 Sep;111(3):604-7.) http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=8780563&query_hl=26&itool=pubmed_DocSum
Lire la suite

Mesalamine in Crohn’s disease with steroid-induced remission: effect on steroid withdrawal and remission maintenance, Groupe d’Etudes Therapeutiques des Affections Inflammatoires Digestives.

Articles,1996
Modigliani R, Colombel JF, Dupas JL, Dapoigny M, Costil V, Veyrac M, Duclos B, Soule JC, Gendre JP, Galmiche JP, Danne O, Cadiot G, Lamouliatte H, Belaiche J, Mary JY. (Gastroenterology 1996 Mar;110(3):688-93.) http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=8608877&query_hl=17&itool=pubmed_DocSum
Lire la suite

Placebo-controlled clinical trial of mesalazine in the prevention of early endoscopic recurrences after resection for Crohn’s disease. Groupe d’Etudes Therapeutiques des Affections Inflammatoires Digestives (GETAID).

Articles,1996
Florent C, Cortot A, Quandale P, Sahmound T, Modigliani R, Sarfaty E, Valleur P, Dupas JL, Daurat M, Faucheron JL, Lerebours E, Michot F, Belaiche J, Jacquet N, Soule JC, Rothman N, Gendre JP,…
Lire la suite

Identifying patients with a high risk of relapse in quiescent Crohn’s disease. The GETAID Group. The Groupe d’Etudes Therapeutiques des Affections Inflammatoires Digestives.

Articles,1995
Sahmoud T, Hoctin-Boes G, Modigliani R, Bitoun A, Colombel JF, Soule JC, Florent C, Gendre JP, Lerebours E, Sylvester R. (Gut 1995 Dec;37(6):811-8.) http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=8537053&query_hl=1&itool=pubmed_docsum
Lire la suite

Treatment of Crohn’s disease by lymphocyte apheresis: a randomized controlled trial. Groupe d’Etudes Therapeutiques des Affections Inflammatoires Digestives.

Articles,1994
Lerebours E, Bussel A, Modigliani R, Bastit D, Florent C, Rabian C, Rene E, Soule JC. (Gastroenterology. 1994 Aug;107(2):357-61.) http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=8039612&query_hl=17&itool=pubmed_DocSum
Lire la suite

Correlations between clinical activity, endoscopic severity, and biological parameters in colonic or ileocolonic Crohn’s disease. A prospective multicentre study of 121 cases. The Groupe d’Etudes Therapeutiques des Affections Inflammatoires Digestives.

Articles,1994
Cellier C, Sahmoud T, Froguel E, Adenis A, Belaiche J, Bretagne JF, Florent C, Bouvry M, Mary JY, Modigliani R. (Gut. 1994 Feb;35(2):231-5.) http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=7508411&query_hl=17&itool=pubmed_DocSum
Lire la suite

Oral mesalamine (Pentasa) as maintenance treatment in Crohn’s disease: a multicenter placebo-controlled study. The Groupe d’Etudes Therapeutiques des Affections Inflammatoires Digestives (GETAID).

Articles,1993
Gendre JP, Mary JY, Florent C, Modigliani R, Colombel JF, Soule JC,Galmiche JP, Lerebours E, Descos L, Viteau JM, et al. (Gastroenterology. 1993 Feb;104(2):435-9.) http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=8425685&query_hl=1&itool=pubmed_docsum
Lire la suite

Clinical, biological, and endoscopic picture of attacks of Crohn’s disease. Evolution on prednisolone. Groupe d’Etude Therapeutique des Affections Inflammatoires Digestives.

Articles,1990
Modigliani R, Mary JY, Simon JF, Cortot A, Soule JC, Gendre JP, Rene E. (Gastroenterology. 1990 Apr;98(4):811-8.) http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=2179031&query_hl=5&itool=pubmed_docsum
Lire la suite

Development and validation of an endoscopic index of the severity for Crohn’s disease: a prospective multicentre study. Groupe d’Etudes Therapeutiques des Affections Inflammatoires du Tube Digestif (GETAID).

Articles,1989
Mary JY, Modigliani R. (Gut. 1989 Jul;30(7):983-9.) http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=2668130&query_hl=1&itool=pubmed_docsum
Lire la suite

Effect of levamisole on the prevention of developmental flare-ups in quiescent Crohn’s disease: a prospective multicenter controlled trial in 155 patients Gastroenterol Clin Biol.

Articles,1983
Modigliani R, Pieddeloup C, Hecketsweiler P, Descos L, Lerebours E, Vernisse B, Costil V, Bitoun A, Lacroute JM, Maire P, et al. (1983 Aug-Sep;7(8-9):683-92.) http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=6352383&query_hl=17&itool=pubmed_DocSum
Lire la suite

Nodular regenerative hyperplasia in patients with inflammatory bowel disease treated with azathioprine.

Articles,2007
Vernier-Massouille G, Cosnes J, Lemann M, Marteau P, Reinisch W, Laharie D, Cadiot G, Bouhnik Y, De Vos M, Bourreille A, Duclos B, Seksik P, Mary JY, Colombel JF. (Gut. 2007 May 15) http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=17504943&ordinalpos=2&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
Lire la suite

A simple biological score for predicting low risk of short-term relapse in Crohn’s disease

Articles,2006
Consigny Y, Modigliani R, Colombel JF, Dupas JL, Lémann M, Mary JY; Groupe d’Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID). (IBD 2006 Jul;12(7):551-7.) http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=16804391&ordinalpos=13&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
Lire la suite

A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis

Articles,2007
D’Haens G, Sandborn WJ, Feagan BG, Geboes K, Hanauer SB, Irvine EJ, Lémann M, Marteau P, Rutgeerts P, Schölmerich J, Sutherland LR. (Gastroenterology. 2007 Feb;132(2):763-86. Epub 2006 Dec 20.) http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=17258735&ordinalpos=6&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
Lire la suite

Multidrug resistance gene-1 polymorphisms and resistance to cyclosporine A in patients with steroid resistant ulcerative colitis.

Articles,2007
Daniel F, Loriot MA, Seksik P, Cosnes J, Gornet JM, Lémann M, Fein F, Vernier-Massouille G, De Vos M, Boureille A, Treton X, Flourié B, Roblin X, Louis E, Zerbib F, Beaune P, Marteau…
Lire la suite

Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn’s disease – A randomized, double-blind, placebo-controlled GETAID trial

Articles,2006
Marteau P, Lémann M, Seksik P, Laharie D, Colombel JF, Bouhnik Y, Cadiot G, Soulé JC, Bourreille A, Metman E, EH, Lerebours E, Carbonnel F, Dupas JL, Veyrac M, Coffin B, Moreau J, Mary…
Lire la suite

Infliximab plus azathioprine for steroid-dependent Crohn’s disease patients: a randomized placebo-controlled trial

Articles,2006
Lemann M, Mary JY, Duclos B, Veyrac M, Dupas JL, Delchier JC, Laharie D, Moreau J, Cadiot G, Picon L, Bourreille A, Sobahni I, Colombel JF and the GETAID. (Gastroenterology. 2006 Apr;130(4):1054-61.) https://www.ncbi.nlm.nih.gov/pubmed/16618399?dopt=Abstract
Lire la suite

A Randomized, Double-Blind, Controlled Withdrawal Trial in Crohn’s Disease Patients in Long-term Remission on Azathioprine

Articles,2005
Lemann M, Mary JY, Colombel JF, Duclos B, Soule JC, Lerebours E, Modigliani R, Bouhnik Y. and GETAID. (Gastroenterology. 2005 Jun;128(7):1812-8.) http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15940616&query_hl=17&itool=pubmed_docsum
Lire la suite

ITPA genotyping test does not improve detection of Crohn’s disease patients at risk of azathioprine/6-mercaptopurine induced myelosuppression.

Articles,2005
Allorge D, Hamdan R, Broly F, Libersa C, Colombel JF. (Gut. 2005 Apr;54(4):565.) http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15753546&query_hl=31&itool=pubmed_DocSum
Lire la suite

Small bowel adenocarcinoma in patients with Crohn’s disease compared with small bowel adenocarcinoma de novo

Articles,2005
Palascak-Juif V, Bouvier AM, Cosnes J, Flourié B, Bouché O, Cadiot G, Lémann M, Bonaz B, Denet C, Marteau P, Gambiez L, Beaugerie L, Faivre J, Carbonnel F. (IBD 2005 Sep;11(9):828-32.) http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=16116317&ordinalpos=20&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
Lire la suite

Clustering of Crohn’s disease within affected sibships. Eur J Hum Genet.

Articles,2003
Hugot JP, Cezard JP, Colombel JF, Belaiche J, Almer S, Tysk C, Montague S, Gassull M, Christensen S, Finkel Y, Gower-Rousseau C, Modigliani R, Zouali H, Lesage S, Chamaillard M, Macry J, Thomas G,…
Lire la suite

Tioguanine in patients with Crohn’s disease intolerant or resistant to azathioprine/mercaptopurine.

Articles,2003
Bonaz B, Boitard J, Marteau P, Lemann M, Coffin B, Flourie B, Belaiche, J Cadiot G, Metman EH, Cortot A, Colombel JF; Getaid. (Aliment Pharmacol Ther. 2003 Aug 15;18(4):401-8.) http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12940925&query_hl=1&itool=pubmed_docsum
Lire la suite

Osteoporosis in inflammatory bowel disease: effect of calcium and vitamin D with or without fluoride Aliment Pharmacol Ther

Articles,2002
Abitbol V, Mary JY, Roux C, Soule JC, Belaiche J, Dupas JL, Gendre JP, Lerebours E, Chaussade S; Groupe D’etudes Therapeutiques des Affections Inflammatoires Digestives (GETAID). (2002 May;16(5):919-27 PMID: 11966500 [PubMed – indexed for…
Lire la suite

CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet

Articles,2002
Lesage S, Zouali H, Cezard JP, Colombel JF, Belaiche J, Almer S, Tysk C, O’Morain C, Gassull M, Binder V, Finkel Y, Modigliani R, Gower-Rousseau C, Macry J, Merlin F, Chamaillard M, Jannot AS,…
Lire la suite

CARD4/NOD1 is not involved in inflammatory bowel disease.

Articles,2001
Zouali H, Lesage S, Merlin F, Cezard JP, Colombel JF, Belaiche J, Almer S, Tysk C, O’Morain C, Gassull M, Christensen S, Finkel Y, Modigliani R, Gower-Rousseau C, Macry J, Chamaillard M, Thomas G,…
Lire la suite

Genetic refinement and physical mapping of a chromosome 16q candidate region for inflammatory bowel disease. Eur J Hum Genet

Articles,2001
Zouali H, Chamaillard M, Lesage S, Cezard JP, Colombel JF, Belaiche J, Almer S, Tysk C, Montague S, Gassull M, Christensen S, Finkel Y, Gower-Rousseau C, Modigliani R, Macry J, Selinger-Leneman H, Thomas G,…
Lire la suite

Genetic analyses of chromosome 12 loci in Crohn’s disease.

Articles,2000
Lesage S, Zouali H, Colombel JF, Belaiche J, Cezard JP, Tysk C, Almer S, Gassull M, Binder V, Chamaillard M, Le Gall I, Thomas G, Hugot JP. (Gut. 2000 Dec;47(6):787-91.) http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=11076876&query_hl=26&itool=pubmed_DocSum
Lire la suite

Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn’s disease.Nature.

Articles,2001
Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, Belaiche J, Almer S, Tysk C, O’Morain CA, Gassull M, Binder V, Finkel Y, Cortot A, Modigliani R,Laurent-Puig P, Gower-Rousseau C, Macry J, Colombel…
Lire la suite

Health-related quality of life in Crohn’s disease: a prospective longitudinal study in 231 patients. Am J Gastroenterol.

Articles,2001
Blondel-Kucharski F, Chircop C, Marquis P, Cortot A, Baron F, Gendre JP, Colombel JF; Groupe d’Etudes Therapeutique des Affections Inflammatoires Digestives (GETAID). (2001 Oct;96(10):2915-20.) http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=11693326&query_hl=1&itool=pubmed_docsum
Lire la suite

Genotypic analysis of thiopurine S-methyltransferase in patients with Crohn’s disease and severe myelosuppression during azathioprine therapy.

Articles,2000
Colombel JF, Ferrari N, Debuysere H, Marteau P, Gendre JP, Bonaz B, Soule JC, Modigliani R, Touze Y, Catala P, Libersa C, Broly F. (Gastroenterology 2000 Jun;118(6):1025-30.) http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=10833476&query_hl=17&itool=pubmed_DocSum
Lire la suite

A controlled trial comparing ciprofloxacin with mesalazine for the treatment of active Crohn’s disease. Groupe d’Etudes Therapeutiques des Affections Inflammatoires Digestives ( GETAID ).

Articles,1999
Colombel JF, Lemann M, Cassagnou M, Bouhnik Y, Duclos B, Dupas JL, Notteghem B, Mary JY. (Am J Gastroenterol 1999 Mar;94(3):674-8.) http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=10086650&query_hl=1&itool=pubmed_docsum
Lire la suite

Risk factors associated with small bowel Adenocarcinoma in Crohn’s disease: A case–control study

Articles,2009
Piton G, Cosnes J, Monnet E, Beaugerie L, Seksik P, Savoye G, Cadiot G, Flourie B, Capelle P, Marteau P, Lemann M, Colombel JF, Khouri E, Bonaz B, Carbonnel F.(Am J Gastroenterol 2008;103:1–7) http://www.ncbi.nlm.nih.gov/pubmed/18564124
Lire la suite

Cyclosporine treatment of steroid-refractory ulcerative colitis during pregnancy

Articles,2009
Branche J, Cortot A, Bourreille A, Coffin B, De Vos M, de Saussure P, Seksik P, Marteau P, Lemann M, Colombel. (IBD-08-0232.R1) http://www.ncbi.nlm.nih.gov/pubmed/19137604
Lire la suite

Azathioprine Withdrawal in Patients With Crohn’s Disease Maintained on Prolonged Remission: A High Risk of Relapse

Articles,2009
Treton X, Bouhnik Y, Mary JY, Colombel JF, Duclos B, Soule JC, Lerebours E, Cosnes J, Lémann M, and the Groupe d’Études Thérapeutiques des Affections Inflammatoires du tube Digestif (GETAID). (Clinical Gastroenterology and Hepatolgy…
Lire la suite

Fibrin glue is effective healing perianal fistulas in patients with Crohn’s disease

Articles,2010
Grimaud JC, Munoz-Bongrand N, Siproudhis L, Abramowitz L, Sénéjoux A, Vitton V, Gambiez L, Flourié B, Hébuterne X, Louis E, Coffin B, De Parades V, Savoye G, Soulé JC, Bouhnik Y, Colombel JF, Contou…
Lire la suite

Safety and efficacy of extractible self-expandable metal stents in the treatment of Crohn’s disease intestinal strictures: a prospective pilot study

Articles,2012
Attar A, Maunoury V, Vahedi K, Vernier-Massouille G, Vida S, Bulois P, Colombel JF, Bouhnik Y; GETAID. (Inflamm Bowel Dis. 2012 Oct;18(10):1849-54. doi: 10.1002/ibd.22844. Epub 2011 Dec 11) http://www.ncbi.nlm.nih.gov/pubmed/22161935
Lire la suite

Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial

Articles,2012
Laharie D, Bourreille A, Branche J, Allez M, Bouhnik Y, Filippi J, Zerbib F, Savoye G, Nachury M, Moreau J, Delchier JC, Cosnes J, Ricart E, Dewit O, Lopez-Sanroman A, Dupas JL, Carbonnel F,…
Lire la suite

Portomesenteric Vein Thrombosis in Patients With Inflammatory Bowel Disease

Articles,2013
Landman C, Nahon S, Cosnes J, Bouhnik Y, Brixi-Benmansour H, Bouguen G, Colombel JF, Savoye G, Coffin B, Abitbol V, Filippi J, Laharie D, Moreau J,Veyrac M, Allez M, Marteau P. (Inflamm Bowel Dis.…
Lire la suite

Randomized Controlled Trial

Articles,2013
Cosnes J, Bourrier A, Laharie D, Nahon S, Bouhnik Y, Carbonnel F, Allez M, Dupas JL, Reimund JM, Savoye G, Jouet P, Moreau J, Mary JY, Colombel JF. (Gastroenterology. 2013 Apr 30. pii: S0016-5085(13)00699-9.…
Lire la suite

Detection of Dysplasia or Cancer in 3.5% of Patients with Inflammatory Bowel Disease and Colonic Strictures

Articles,2015
Fumery M, de Chambrun GP, Stefanescu C, Buisson A, Bressenot A, Beaugerie L, Amiot A, Altwegg R, Savoye G, Abitbol V, Bouguen G, Simon M, Duffas JP, Hébuterne X, Nancey S, Roblin X, Leteurtre…
Lire la suite

La version de votre navigateur est obsolète et votre appareil est exposé à des risques de sécurité.

Pour profiter d'une expérience optimale sur ce site il est fortement recommandé de mettre à jour votre navigateur ou d'en installer un autre :